发明名称 APELIN FUSION PROTEINS AND USES THEREOF
摘要 The invention provides a fusion protein or polypeptide comprising an apelin peptide fused to a multimerizing component. The invention also provides a fusion protein or polypeptide comprising an apelin peptide fused to an Fc domain, a fragment of an Fc domain, or a variant of an Fc domain. Apelin Fc-fusion polypeptides are capable of binding to the apelin receptor (APLNR). Apelin Fc-fusion polypeptides are capable of activating the APLNR and have improved pharmacokinetic properties compared to apelin peptides that are not fused to an Fc or an Fc fragment. Apelin Fc-fusion polypeptides are useful in diseases and conditions related to cardiovascular function, diabetes, cancer, obesity and other apelin-related conditions.
申请公布号 SG11201506335Y(A) 申请公布日期 2015.09.29
申请号 SG11201506335Y 申请日期 2014.03.14
申请人 REGENERON PHARMACEUTICALS, INC. 发明人 STEVIS, PANAYIOTIS;GROMADA, JESPER;MURPHY, ANDREW
分类号 C07K14/47;A61K38/10;A61K38/17;C07K7/08 主分类号 C07K14/47
代理机构 代理人
主权项
地址